Longevity Lab Report
← All supplements

Valerian Root

The sleep herb people feel working that sleep labs mostly cannot measure

C-

Evidence grade

C-

Worth it

$8-15/month

Typical cost

DoseTrials used roughly 300 to 600 mg of root extract before bed, but standardization to valerenic acids is inconsistent across products and trials, so the trialed range describes what was studied rather than a dose known to work. No effective dose has been established.

BasisMeta-analyses (Bent et al., American Journal of Medicine 2006; Fernandez-San-Martin et al., Sleep Medicine 2010) find a subjective sleep-quality signal amid substantial heterogeneity, with no consistent improvement on objective measures (polysomnography, actigraphy).

Valerian root extract is sold for sleep and anxiety. We grade Valerian Root C- on evidence and C- for worth-it at about $8-15 per month.

What it does

Valerian root extract is sold for sleep and anxiety. Its active chemistry (valerenic acids and related compounds) touches GABA signaling in animal work. In human trials the pattern is consistent across two decades: people report sleeping somewhat better, objective sleep measures mostly do not move, and the American Academy of Sleep Medicine recommends against it for insomnia on the evidence as it stands.

What the research says

  • Improves subjective sleep quality in insomnia

    Evidence: C-. Pooled self-report measures improve modestly in some analyses; heterogeneity is high and the effect is not matched by objective sleep measures.

  • Reduces anxiety symptoms

    Evidence: D+. A few small trials with mixed results; no base adequate to grade higher.

Meta-analyses (Bent et al., American Journal of Medicine 2006; Fernandez-San-Martin et al., Sleep Medicine 2010) find a subjective sleep-quality signal amid substantial heterogeneity, with no consistent improvement on objective measures (polysomnography, actigraphy). Trial quality is uneven, preparations are poorly standardized, and publication bias is suspected. A real reported effect with no objective confirmation and a guideline recommendation against the use is a C- shape in this library.

Is it worth it?

C-Worth it

The derivation follows the record: a C- evidence base with an objective-measure null and a specialty-society recommendation against the use prices a cheap product low anyway, because the purchase buys a reported feeling the instruments do not confirm. The taper and interaction notes are part of the value judgment.

Typical cost

$8-15/month

Common form, not a brand recommendation

Dosage context verified

Trials used roughly 300 to 600 mg of root extract before bed, but standardization to valerenic acids is inconsistent across products and trials, so the trialed range describes what was studied rather than a dose known to work. No effective dose has been established.

The worth-it ranking

Valerian Root sits outside the worth-it ranking of 38.

Valerian Root sits outside that ranking of 38. The leaders below clear an evidence floor of B- before price counts at all, so cheap alone never earns a rank.

  1. 1AWorth itCreatine evidence A-~$5-10/mo
  2. 2AWorth itCaffeine evidence B+~$5-10/mo
  3. 3AWorth itVitamin D evidence B~$5-8/mo

See the full ranking of 38 →

When the evidence moves a grade, this ranking moves with it. Thursday is where you hear it first.

Safety notes

Sedative additivity is the practical centre: valerian stacks with alcohol, benzodiazepines, Z-drugs, and sedating antihistamines. Dependence is documented in case reports, including a withdrawal syndrome with delirium after abrupt cessation of chronic high-dose use, so long-term users should taper rather than stop suddenly. Rare hepatotoxicity case reports exist, mostly involving multi-ingredient products, with causality unsettled. Next-day grogginess and vivid dreams are the common complaints; a minority report paradoxical stimulation. Insufficient safety data in pregnancy and breastfeeding: avoid.

Changelog

Last updated 2026-11-07

  • 2026-11-07|Initial grading: evidence C-, worth-it C-. The record's structure is the subjective-versus-objective split: meta-analyses find reported sleep-quality improvement without consistent objective confirmation, and the American Academy of Sleep Medicine recommends against valerian for insomnia.

The week's longevity and biohacking news.

Every story graded against the evidence. Free. Unsubscribe anytime.

The week's longevity and biohacking news. Every story graded against the evidence. Free. Unsubscribe anytime.

Every grade follows a published rubric. Sponsors do not influence findings or grades.